Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002701:Chloramphenicol / Q000627:therapeutic use*; D003879:Dermatologic Agents; D004917:Erythromycin / Q000627:therapeutic use*; D008837:Micrococcus / Q000472:pathogenicity* / Q000628:therapy*; D009675:Novobiocin; D013203:Staphylococcal Infections
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D009675:Novobiocin; D004917:Erythromycin; D002701:Chloramphenicol
ANTIBIOTICS/therapeutic use; CHLORAMPHENICOL/therapeutic use; ERYTHROMYCIN/therapeutic use; MICROCOCCAL INFECTIONS/therapy